Best Short-Term Stocks to Buy Now with Strong Analyst Upside Potential

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  21 Jul 2025
 

•   CLF  
   
  0.00%
•   CRNX  
   
  0.00%
•   FRBA  
   
  0.00%
•   IQV  
   
  0.00%
•   MSTR  
   
  0.00%

$CLF Cleveland-Cliffs surged 12.45% after Citi raised its price target to $11 following solid Q2 results, but with shares already at $10.66, the implied upside is a modest 3.19%. Still, the stock trades at a compelling level near its 52-week high, with heavy volume and a strong uptrend, reflected in a 72.45 RSI. With a beta of 1.91 and steel demand tailwinds, traders may see momentum continue, though limited near-term upside could cap gains.

$CRNX Crinetics Pharmaceuticals caught attention after H.C. Wainwright reiterated its Buy rating with a bullish $81 price target, suggesting a massive 161.71% upside from its current $30.95. Despite being in a downtrend, this small-cap biotech remains one to watch for patient traders seeking high-risk, high-reward plays, as it is trading closer to its 52-week low with room for a dramatic rebound on clinical catalysts.

$FRBA Investors looking for steady potential can look at First Bank, which trades at $15.53 with an 8% upside to its $16.77 target. The bank benefits from technical support near the 50 EMA, although weak momentum lingers in the sector. With a low beta of 0.76 and stable PE of 10.05, FRBA aligns well with conservative traders seeking steady returns amid a sideways trend.

$IQV IQVIA Holdings is heading into its earnings with analysts expecting continued solid performance. Trading at $158.96 with a target of $166.68 implies a 4.86% upside. Shares have rebounded into an uptrend, supported by a 50.56 RSI and improving momentum. Given its 21.66 PE and steady growth, IQV offers an attractive near-term watch for traders seeking moderate upside around earnings catalysts.

$MSTR MicroStrategy has a new Street-high target of $680, offering a notable 59.52% upside from its current $426.28. The stock is in a strong uptrend, with an RSI of 56.02 and recent price action above its key moving averages. Given its Bitcoin exposure and potential for further crypto sector tailwinds, MSTR may deliver outsized returns for traders comfortable with volatility.

$NET Cloudflare received dual price target upgrades from RBC and Wells Fargo to $210 and $225, respectively, suggesting potential upside between 6.19% and 13.77% from its current $197.76. The stock remains in a healthy uptrend, with a 66.96 RSI and solid momentum supported by recent volume. Traders looking for strong, tech-driven momentum plays may find NET’s near-term upside compelling as it tests its 52-week highs.

$OMCL Omnicell saw its price target lifted to $40 by Wells Fargo, signaling a robust 42.70% upside from its current $28.03. The stock is rebounding with a 4.28% daily gain but remains in a downtrend. With a low beta of 0.76, OMCL provides an interesting setup for reversal traders seeking significant upside if sentiment shifts and tariff relief continues to boost fundamentals.

$SAN Banco Santander Chile appears to offer the largest percentage upside on paper, with a massive 177.97% implied gain to its $23.60 target from its current $8.49. The stock is in an uptrend, trading with a 55.63 RSI and steady technical levels. However, such large target differentials typically require substantial fundamental catalysts or market re-ratings, so traders should remain cautious and watch for confirmation of the trend.